FDA Adverse Event Malfunction Summary report: N

COVID-19 ANTIBODY COMPREHENSIVE TEST

MDR report key: 16103040 · Received January 4, 2023

Report

Report Number
MW5114159
Event Type
Malfunction
Date Received
January 4, 2023
Date of Event
December 13, 2022
Report Date
December 31, 2022
Manufacturer
UNK
Product Code
QKO
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
NH, US
Reporter Occupation
PATIENT
Health Professional
*

Narratives

Description of Event or Problem · 0

WE HAVE THREE MEMBERS IN OUR HOUSEHOLD (ONE OF WHOM IS NOT BIOLOGICALLY RELATED) WHO COULD NOT OBTAIN ENOUGH BLOOD TO PROVIDE A SAMPLE SUFFICIENT FOR TESTING DESPITE EXPLICITLY FOLLOWING ALL DIRECTIONS. WE CALLED THE COMPANY (4U HEALTH); THE CO-FOUNDER, "(B)(6)," INSTRUCTED US TO RUN OUR HANDS UNDER WARM WATER AND ASSURED US THAT THIS REMEDY WORKED "99% OF THE TIME." ALL THREE OF US MADE A SUBSEQUENT ATTEMPT FOLLOWING THIS ADDITIONAL INSTRUCTION AND STILL COULD NOT OBTAIN A SUFFICIENT SAMPLE. WE HAVE LEFT MULTIPLE MESSAGES FOR THE COMPANY SINCE THEN AND HAVE NOT RECEIVED A CALL BACK. WE BELIEVE THIS PRODUCT IS NOT USER-FRIENDLY TO THE AVERAGE PERSON AND SHOULD NOT BE MARKETED TO THE GENERAL PUBLIC.

Description of Event or Problem · 0

ADDITIONAL INFORMATION RECEIVED ON 01/11/2022 FOR REPORT MW5114159 TO UPDATE PROCODE TO QKO.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
122434 COVID-19 ANTIBODY COMPREHENSIVE TEST REAGENT, CORONAVIRUS SEROLOGICAL QKO UNK
1258662 COVID-19 ANTIBODY COMPREHENSIVE TEST REAGENT, CORONAVIRUS SEROLOGICAL QKO UNK
1258663 COVID-19 ANTIBODY COMPREHENSIVE TEST REAGENT, CORONAVIRUS SEROLOGICAL QKO UNK
1258664 COVID-19 ANTIBODY COMPREHENSIVE TEST REAGENT, CORONAVIRUS SEROLOGICAL QKO UNK

Patients

Seq Age Sex Outcome Treatment
1 68 YR Male ALFUZOSIN| AMOXICILLIN| ASPIRIN | ATORVASTATIN | CENTRUM SILVER| PLAVIX